Owens Stephanie M, Brozanski Beverly S, Meyn Leslie A, Wiesenfeld Harold C
From the Departments of Obstetrics, Gynecology and Reproductive Sciences and Pediatrics, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, Pittsburgh, Pennsylvania.
Obstet Gynecol. 2009 Sep;114(3):573-579. doi: 10.1097/AOG.0b013e3181b490f1.
To estimate the effect of a hospital-wide change in the timing of antimicrobial prophylaxis in cesarean deliveries on maternal and neonatal infections.
In November 2004, our institution instituted guidelines recommending that the administration of antimicrobial prophylaxis for cesarean delivery be administered before skin incision rather than after umbilical-cord clamping. We reviewed all cesarean deliveries from two time periods. Group 1 received antibiotics after umbilical-cord clamping (July 2002 to November 2004). Group 2 received antibiotics before skin incision (June 2005 to August 2007). Rates of maternal and neonatal infectious complications were compared between groups.
There were 4,229 cesarean deliveries in group 1 and 4,781 cesarean deliveries in group 2. Compared with women receiving antimicrobial prophylaxis after umbilical-cord clamping, those administered antimicrobial prophylaxis before skin incision had lower rates of postpartum endometritis (2.2% compared with 3.9%) and wound infection (2.5% compared with 3.6%). After multivariable logistic regression, antimicrobial prophylaxis before skin incision remained associated with lower rates of endometritis (odds ratio [OR] 0.61, 95% confidence interval [CI] 0.47-0.79) and wound infection (OR 0.70, 95% CI 0.55-0.90). Antimicrobial prophylaxis before skin incision had no adverse effect on neonatal infection rates or on the evaluation of the neonate.
Antimicrobial prophylaxis before skin incision, compared with after cord clamping, resulted in lower rates of maternal infections and had no effect on neonatal infections. Antimicrobial prophylaxis for cesarean delivery should occur before skin incision, consistent with basic tenets of surgical antimicrobial prophylaxis.
II.
评估剖宫产术中抗菌药物预防性应用时机全院性改变对孕产妇及新生儿感染的影响。
2004年11月,我院制定指南,建议剖宫产抗菌药物预防性应用应在皮肤切开前而非脐带夹闭后进行。我们回顾了两个时间段的所有剖宫产病例。第1组在脐带夹闭后接受抗生素治疗(2002年7月至2004年11月)。第2组在皮肤切开前接受抗生素治疗(2005年6月至2007年8月)。比较两组孕产妇及新生儿感染并发症的发生率。
第1组有4229例剖宫产,第2组有4781例剖宫产。与在脐带夹闭后接受抗菌药物预防性应用的女性相比,在皮肤切开前接受抗菌药物预防性应用的女性产后子宫内膜炎发生率较低(分别为2.2%和3.9%),伤口感染发生率也较低(分别为2.5%和3.6%)。多变量逻辑回归分析后,皮肤切开前的抗菌药物预防性应用仍与较低的子宫内膜炎发生率(比值比[OR]0.61,95%置信区间[CI]0.47 - 0.79)和伤口感染发生率(OR 0.70,95%CI 0.55 - 0.90)相关。皮肤切开前的抗菌药物预防性应用对新生儿感染率或新生儿评估无不良影响。
与脐带夹闭后相比,皮肤切开前的抗菌药物预防性应用可降低孕产妇感染率,且对新生儿感染无影响。剖宫产抗菌药物预防性应用应在皮肤切开前进行,这与外科抗菌药物预防性应用的基本原则一致。
II级